Quest Historical Balance Sheet

QPT Stock  CAD 0.02  0.01  33.33%   
Trend analysis of Quest PharmaTech balance sheet accounts such as Accounts Payable of 116.2 K, Cash of 700.9 K, Net Receivables of 267.2 K or Total Liab of 1.1 M provides information on Quest PharmaTech's total assets, liabilities, and equity, which is the actual value of Quest PharmaTech to its prevalent stockholders. By breaking down trends over time using Quest PharmaTech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quest PharmaTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Quest Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Quest PharmaTech at a specified time, usually calculated after every quarter, six months, or one year. Quest PharmaTech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Quest PharmaTech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Quest currently owns. An asset can also be divided into two categories, current and non-current.

Quest PharmaTech Balance Sheet Chart

At this time, Quest PharmaTech's Property Plant And Equipment Gross is fairly stable compared to the past year.

Total Assets

Total assets refers to the total amount of Quest PharmaTech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Quest PharmaTech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Quest PharmaTech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Quest PharmaTech are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Quest PharmaTech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Quest PharmaTech are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most accounts from Quest PharmaTech's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Quest PharmaTech current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quest PharmaTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Quest PharmaTech's Property Plant And Equipment Gross is fairly stable compared to the past year.
 2022 2023 2024 2025 (projected)
Total Current Liabilities1.1M1.3M1.2M1.1M
Total Assets84.4M24.5M28.1M38.7M

Quest PharmaTech balance sheet Correlations

-0.330.990.870.95-0.3-0.360.14-0.36-0.230.280.49-0.37-0.5-0.510.35-0.43-0.15-0.510.990.30.990.07-0.030.990.02
-0.33-0.44-0.5-0.480.780.57-0.341.00.280.210.26-0.260.660.760.27-0.260.490.01-0.38-0.15-0.38-0.230.2-0.41-0.69
0.99-0.440.880.97-0.37-0.390.17-0.46-0.290.230.44-0.31-0.58-0.580.3-0.37-0.18-0.470.990.340.990.08-0.040.990.09
0.87-0.50.880.81-0.43-0.320.55-0.52-0.380.320.53-0.4-0.73-0.660.36-0.45-0.41-0.580.90.390.90.46-0.390.920.06
0.95-0.480.970.81-0.39-0.470.06-0.5-0.370.010.27-0.13-0.56-0.660.13-0.18-0.08-0.290.950.320.95-0.020.070.950.16
-0.30.78-0.37-0.43-0.390.76-0.310.790.130.120.03-0.090.420.480.1-0.050.750.04-0.310.03-0.32-0.210.19-0.35-0.79
-0.360.57-0.39-0.32-0.470.76-0.020.580.190.20.2-0.040.140.420.04-0.130.47-0.1-0.370.14-0.370.08-0.06-0.38-0.66
0.14-0.340.170.550.06-0.31-0.02-0.36-0.280.340.35-0.32-0.59-0.340.26-0.33-0.66-0.420.190.240.20.75-0.690.250.04
-0.361.0-0.46-0.52-0.50.790.58-0.360.260.210.21-0.210.670.740.22-0.210.520.05-0.4-0.15-0.4-0.250.22-0.44-0.68
-0.230.28-0.29-0.38-0.370.130.19-0.280.260.170.13-0.260.660.680.26-0.32-0.04-0.35-0.31-0.65-0.31-0.190.16-0.320.01
0.280.210.230.320.010.120.20.340.210.170.61-0.63-0.070.170.64-0.64-0.29-0.560.250.150.250.3-0.180.27-0.25
0.490.260.440.530.270.030.20.350.210.130.61-0.81-0.20.180.84-0.93-0.36-0.80.450.310.450.33-0.150.46-0.41
-0.37-0.26-0.31-0.4-0.13-0.09-0.04-0.32-0.21-0.26-0.63-0.810.06-0.37-0.960.950.390.75-0.34-0.11-0.34-0.280.24-0.350.33
-0.50.66-0.58-0.73-0.560.420.14-0.590.670.66-0.07-0.20.060.74-0.030.070.370.14-0.55-0.59-0.56-0.420.36-0.59-0.24
-0.510.76-0.58-0.66-0.660.480.42-0.340.740.680.170.18-0.370.740.37-0.330.17-0.05-0.57-0.35-0.58-0.260.22-0.6-0.34
0.350.270.30.360.130.10.040.260.220.260.640.84-0.96-0.030.37-0.91-0.36-0.710.30.190.30.28-0.090.31-0.32
-0.43-0.26-0.37-0.45-0.18-0.05-0.13-0.33-0.21-0.32-0.64-0.930.950.07-0.33-0.910.410.87-0.39-0.13-0.39-0.30.25-0.40.38
-0.150.49-0.18-0.41-0.080.750.47-0.660.52-0.04-0.29-0.360.390.370.17-0.360.410.43-0.16-0.02-0.16-0.470.42-0.21-0.44
-0.510.01-0.47-0.58-0.290.04-0.1-0.420.05-0.35-0.56-0.80.750.14-0.05-0.710.870.43-0.49-0.13-0.49-0.370.3-0.510.37
0.99-0.380.990.90.95-0.31-0.370.19-0.4-0.310.250.45-0.34-0.55-0.570.3-0.39-0.16-0.490.331.00.12-0.111.00.01
0.3-0.150.340.390.320.030.140.24-0.15-0.650.150.31-0.11-0.59-0.350.19-0.13-0.02-0.130.330.320.230.020.33-0.36
0.99-0.380.990.90.95-0.32-0.370.2-0.4-0.310.250.45-0.34-0.56-0.580.3-0.39-0.16-0.491.00.320.12-0.111.00.02
0.07-0.230.080.46-0.02-0.210.080.75-0.25-0.190.30.33-0.28-0.42-0.260.28-0.3-0.47-0.370.120.230.12-0.840.16-0.03
-0.030.2-0.04-0.390.070.19-0.06-0.690.220.16-0.18-0.150.240.360.22-0.090.250.420.3-0.110.02-0.11-0.84-0.150.01
0.99-0.410.990.920.95-0.35-0.380.25-0.44-0.320.270.46-0.35-0.59-0.60.31-0.4-0.21-0.511.00.331.00.16-0.150.04
0.02-0.690.090.060.16-0.79-0.660.04-0.680.01-0.25-0.410.33-0.24-0.34-0.320.38-0.440.370.01-0.360.02-0.030.010.04
Click cells to compare fundamentals

Quest PharmaTech Account Relationship Matchups

Quest PharmaTech balance sheet Accounts

202020212022202320242025 (projected)
Total Assets175.6M91.0M84.4M24.5M28.1M38.7M
Total Current Liabilities375.4K622.6K1.1M1.3M1.2M1.1M
Total Stockholder Equity175.2M90.4M83.3M23.2M26.6M31.3M
Net Tangible Assets(15.3M)175.2M90.4M83.3M95.7M100.5M
Retained Earnings133.8M48.8M41.5M(19.1M)(21.9M)(20.8M)
Accounts Payable5.9M85.1K108.6K106.4K122.4K116.2K
Cash199.1K264.3K374.7K717.0K824.5K700.9K
Net Receivables10.9K32.7K320.0221.3K254.5K267.2K
Total Liab389.4K622.6K1.1M1.3M1.2M1.1M
Total Current Assets281.5K288.2K621.5K835.5K752.0K714.4K
Common Stock30.5M30.6M30.6M30.7M35.4M29.4M
Other Stockholder Equity1.2M844.7K(50.3K)(114.5K)(103.0K)(97.9K)
Property Plant Equipment99.2K55.0K16.5K3.0K2.7K2.5K
Non Current Assets Total175.3M90.7M83.7M23.6M27.2M52.0M
Long Term Investments175.3M90.7M83.7M23.6M27.2M51.5M
Common Stock Shares Outstanding167.4M167.7M168.2M169.1M194.5M185.0M
Net Invested Capital175.5M90.9M84.3M24.2M27.8M54.1M
Net Working Capital(53.6K)(334.4K)(484.9K)(487.2K)(560.3K)(588.4K)
Net Debt50.9K235.7K625.3K283.0K325.5K371.4K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Quest Stock Analysis

When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.